$TJX

Herrman Ernie sold $4.4M of TJX

Herrman Ernie (CEO & President) sold 28,000 shares of TJX COMPANIES INC /DE/ (TJX) at $158.32 ($4.43M total) on 2026-06-04.

Original reporting
SEC EDGAR · Herrman Ernie
Published Jun 5, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 5, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TJX
Neutral
medium confidence
Mentioned
$TJX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TJXNeutralLow
01

Why it matters

The market may briefly react to insider selling as a sentiment datapoint, but without accompanying company news it typically does not drive a durable repricing.

02

Market read

A single insider open-market sale by the CEO is disclosed; likely limited incremental information for traders absent other catalysts.

03

What to watch

The filing lacks context (taxes, diversification, compensation timing) and provides no operational or guidance change, limiting causal inference.

Relevance 6/10Novelty 6/10Timing: Filed after-hours (2026-06-05) for a sale executed 2026-06-04

Background

This is an SEC Form 4 insider transaction disclosure for TJX, showing an officer/director open-market sale.

Company-level read

Ticker impact

$TJXNeutralMedium confidence
Context

TJX CEO & President Herrman Ernie sold 28,000 shares in an open-market transaction reported on SEC Form 4.

Expected impact

Low likelihood of a sustained price move solely from this sale; any effect is likely short-lived.

Evidence & confidence

The filing is a routine insider open-market sale with no stated reason and no 10b5-1 plan disclosed; size is notable but not clearly market-moving by itself.

Market effects

Retail/discount apparel peers may see marginal sentiment read-through, but no sector-wide catalyst is indicated.

None indicated beyond TJX-specific sentiment.

None indicated.

Counterpoint

Insider sales can be planned for diversification or taxes; absence of a disclosed 10b5-1 plan doesn’t necessarily imply negative fundamentals.

Key entities

  • TJX COMPANIES INC /DE/

    Subject company for the insider sale disclosure.

  • Herrman Ernie

    CEO & President who sold 28,000 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TJXHighAI 8/10

TJX Raises Fiscal 2027 Outlook as Q2 Results Show Broad-Based Growth

TJX raised its fiscal 2027 profit and earnings outlook after Q2 results exceeded expectations. Adjusted earnings rose 11% to $1.22 per share, and net sales increased 5% to $15.18 billion. Management also increased its long-term store target. Marmaxx, the largest division, showed the weakest growth at 1%, while other divisions performed better.

$TJXMedAI 8/10

Should Investors Buy TJX as Growth Improves but Valuation Stays Rich?

TJX reported strong Q2 results with rising sales and raised its fiscal 2027 earnings guidance to $5.15-$5.20 per share. The company plans to expand its store count to 7,500 and accelerate growth. However, its valuation remains high, with a forward P/S ratio of 2.06, above industry and historical averages. TJX's cash flow and shareholder returns are robust, but execution and cost pressures remain risks.

$TJXHighAI 8/10

TJX Falls 17.4% in the Past Month as Strong Results Meet Key Risks

TJX Companies Inc. (TJX) shares fell 17.4% in the past month despite beating Q2 earnings estimates and raising its full-year outlook. Q2 sales rose 5% to $15.18B, but Marmaxx's 1% comparable sales growth missed expectations. Management cited merchandise mix issues. TJX faces cost pressures from wages, fuel, and currency fluctuations, with Q3 gross margin expected to decline. The stock's valuation remains high, trading at a premium to its sub-industry and historical median.

$TJXMed

Tjx stock hits 52-week low at 125.5 USD

TJX Companies' stock hit a 52-week low of $125.49, down 26% from its high. Despite a 1-year decline of 9.66% and YTD losses of 17%, InvestingPro suggests it may be undervalued. Q2 fiscal 2027 results beat estimates, with $15.2B revenue and $1.22 EPS. Analysts have mixed views, with Jefferies downgrading to Hold, Bernstein maintaining Outperform, and UBS raising its target to $198.